-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2024.
- InMed Pharmaceuticals Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was -$1.83M, a 16% increase year-over-year.
- InMed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$6.99M, a 4.08% increase from 2023.
- InMed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$7.28M, a 53.3% increase from 2022.
- InMed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$15.6M, a 59.2% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)